PT Phapros, Tbk carries a market capitalization of 216.72B, placing it among publicly traded companies globally. Its enterprise value stands at 810.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 216.72B |
| Enterprise Value | 810.68B |
PT Phapros, Tbk currently has 840.00M shares outstanding.
| Shares Outstanding | 840.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
PT Phapros, Tbk trades at a trailing price-to-earnings ratio of 6.18. The price-to-sales ratio is 0.23, and the price-to-book ratio stands at -0.82.
| PE Ratio | 6.18 |
| PS Ratio | 0.23 |
| PB Ratio | -0.82 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | 29.85 |
| P/OCF Ratio | N/A |
On an enterprise value basis, PT Phapros, Tbk trades at an EV/EBITDA multiple of 8.69 and an EV/FCF ratio of 22.76. The EV/Sales ratio of 0.84 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.69 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.84 |
| EV / EBITDA | 8.69 |
| EV / EBIT | 8.69 |
| EV / FCF | 22.76 |
PT Phapros, Tbk maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 167.50, indicating elevated leverage, while an interest coverage ratio of 2.00 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.10 |
| Quick Ratio | 0.43 |
| Debt / Equity | 167.50 |
| Debt / EBITDA | 7.69 |
| Interest Coverage | 2.00 |
PT Phapros, Tbk posts a return on equity of -773.95 and a return on invested capital of 5.11.
| Return on Equity (ROE) | -773.95 |
| Return on Assets (ROA) | 2.43 |
| Return on Invested Capital (ROIC) | 5.11 |
| Return on Capital Employed (ROCE) | 14.12 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.73 |
Over the trailing twelve months, PT Phapros, Tbk has paid 22.04B in income taxes, reflecting an effective tax rate of 39.24.
| Income Tax | 22.04B |
| Effective Tax Rate | 39.24 |
PT Phapros, Tbk's stock has declined approximately -15.13158% over the past 52 weeks. The 50-day moving average sits at 297.04, while the 200-day moving average is 309.35.
| Beta (5Y) | N/A |
| 52-Week Price Change | -15.13158% |
| 50-Day Moving Average | 297.04 |
| 200-Day Moving Average | 309.35 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, PT Phapros, Tbk generated 961.30B in revenue and converted that into 35.31B in net income, yielding earnings per share of 40.63. EBITDA reached 93.32B, while operating income came in at 93.32B.
| Revenue | 961.30B |
| Gross Profit | 507.32B |
| Operating Income | 93.32B |
| Pretax Income | 56.17B |
| Net Income | 35.31B |
| EBITDA | 93.32B |
| EBIT | 93.32B |
| Earnings Per Share (EPS) | 40.63 |
PT Phapros, Tbk holds 137.18B in cash and equivalents against 717.27B in total debt, resulting in a net debt position of 558.76B. Total book value stands at -264.80B, with working capital of 355.71B providing operational flexibility.
| Cash & Cash Equivalents | 137.18B |
| Total Debt | 717.27B |
| Net Debt | 558.76B |
| Equity (Book Value) | -264.80B |
| Book Value Per Share | -315.24 |
| Working Capital | 355.71B |
After subtracting -7.32B in capital expenditures, free cash flow totaled -7.32B - equivalent to -8.71 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -7.32B |
| Free Cash Flow | -7.32B |
| FCF Per Share | -8.71 |
PT Phapros, Tbk operates with a gross margin of 52.77, reflecting its pricing power and cost economics. The operating margin of 9.71 and net profit margin of 3.67 provide insight into operational efficiency.
| Gross Margin | 52.77 |
| Operating Margin | 9.71 |
| Pretax Margin | 5.84 |
| Profit Margin | 3.67 |
| EBITDA Margin | 9.71 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 42.15 |
| FCF Yield | 3.35 |
PT Phapros, Tbk posts an Altman Z-Score of 1.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.01 |